Medicare Enrolled

Dr. Katherine Labiner, MD

Epilepsy Physician · Austin, TX
Speaking/Promotional
5301 DAVIS LN BLDG A200, Austin, TX 78749
5124944000
In practice since 2011 (14 years)
NPI: 1861788465 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Labiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Labiner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Labiner

Dr. Katherine Labiner is an epilepsy physician in Austin, TX, with 14 years in practice.

Between the years covered by Open Payments, Dr. Labiner received a total of $86,646 from 66 pharmaceutical and/or device companies across 793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Labiner is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice$ $86,646 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$86,646
Total received (2018-2024)
Avg $12,378/year across 7 years
Top 3% in TX for epilepsy physician
66
Companies
793
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,049 (45.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,621 (36.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,976 (18.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$66,522
2023
$4,884
2022
$5,775
2021
$1,627
2020
$3,267
2019
$3,257
2018
$1,314

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$28,535
UCB, Inc.
$23,142
Otter Pharmaceuticals, LLC
$7,104
AQUESTIVE THERAPEUTICS, INC.
$6,840
Neurelis, Inc.
$4,603
JAZZ PHARMACEUTICALS INC.
$3,410
SK Life Science, Inc.
$2,855
LivaNova USA, Inc.
$1,532
Greenwich Biosciences, Inc.
$816
Tris Pharma Inc
$627
Jazz Pharmaceuticals Inc.
$605
NEUROPACE, INC.
$513
Takeda Pharmaceuticals U.S.A., Inc.
$447
UPSHER-SMITH LABORATORIES LLC
$442
Supernus Pharmaceuticals, Inc.
$438
NeuroPace, Inc.
$277
Corium, LLC
$263
Amgen Inc.
$226
Sunovion Pharmaceuticals Inc.
$223
Pyros Pharmaceuticals, Inc.
$217
Ipsen Biopharmaceuticals, Inc
$217
EISAI INC.
$214
Neos Therapeutics, LP
$214
Zogenix Inc.
$208
Abbott Laboratories
$183
IRONSHORE PHARMACEUTICALS INC.
$164
Ironshore Pharmaceuticals Inc.
$164
BIOCODEX, INC.
$153
Sumitomo Pharma America, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$127
GlaxoSmithKline, LLC.
$122
Aucta Pharmaceuticals, Inc.
$112
Biocodex, Inc.
$109
Upsher-Smith Laboratories LLC
$107
Vertical Pharmaceuticals, LLC
$84
Marinus Pharmaceuticals, Inc.
$83
Biohaven Pharmaceutical Holding Company Ltd.
$81
ABBVIE INC.
$78
Saol Therapeutics Inc.
$76
Biogen, Inc.
$74
Aquestive Therapeutics, Inc.
$62
Antares Pharma, Inc.
$61
Shire North American Group Inc
$56
Merz Pharmaceuticals, LLC
$52
Mallinckrodt Hospital Products Inc.
$45
Eisai Inc.
$43
Amneal Pharmaceuticals LLC
$41
Corium, Inc.
$39
GENZYME CORPORATION
$37
Avion Pharmaceuticals
$35
ITF Therapeutics LLC
$35
PIRAMAL CRITICAL CARE
$34
CATALYST PHARMACEUTICALS, INC.
$33
PTC Therapeutics, Inc.
$28
TerSera Therapeutics LLC
$25
E.R. Squibb & Sons, L.L.C.
$25
Adlon Therapeutics L.P.
$24
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$21
Octapharma USA, Inc.
$21
Janssen Biotech, Inc.
$20
Novartis Pharmaceuticals Corporation
$19
ARBOR PHARMACEUTICALS, INC.
$16
Aprecia Pharmaceuticals, LLC
$14
Genentech USA, Inc.
$13
NOBELPHARMA AMERICA, LLC
$12
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 67.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADHANSIA XR · APTIOM · AZSTARYS · Adzenys XR-ODT · Azstarys · BENLYSTA · BOTOX · Briviact · Cenobamate · Cotempla XR-ODT · DAYBUE · DIACOMIT · DYSPORT · Dyanavel XR · Dysport · EMFLAZA · EPIDIOLEX · Edarbi · Enbrel · Epidiolex · Evekeo · FYCOMPA · Fintepla · Fycompa · GABLOFEN · HYFTOR · ILARIS · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LIBERVANT · Lioresal (baclofen) · METHYLPHENIDATE 72 · Methylphenidate Hydrochloride · Motpoly XR · NURTEC ODT · Nayzilam · OCTRODE · ORENCIA · OTREXUP · OXTELLAR XR · PANZYGA · QELBREE · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · Qelbree · Quzyttir · RELEXXII · RNS Neurostimulator Kit · RNS System · Relexxii · SIMPONI · SKYCLARYS · SPINRAZA · SYMPAZAN · Spritam · Sympazan · TORPENZ · TROKENDI XR · VALTOCO · VIGADRONE · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VIGADRONE (vigabatrin) for Oral Solution · VIGPODER · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VYVANSE · Vyvanse · XCOPRI · XYREM · Xeomin · ZOLGENSMA · ZOMIG · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (45%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in epilepsy physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for epilepsy physician in TX.

Looking for a epilepsy physician in Austin?
Compare epilepsy physicians in the Austin area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy Physicians within 10 mi
4
Per 100K population
0.3
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
3.5 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Labiner is a epilepsy physician, and high industry engagement (speaking/promotional, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Labiner receive payments from pharmaceutical companies?
Yes. Dr. Labiner received a total of $86,646 from 66 companies across 793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Labiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Epilepsy Physicians in Austin
Browse epilepsy physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in TX
Epilepsy Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in TX
Which TX epilepsy physicians receive the most from drug and device companies.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
By company
Otter Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Otter Pharmaceuticals, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →